NeuroMetrix, Inc. Common Stock
NURO
NURO was delisted on the 1st of May, 2025.
14 hedge funds and large institutions have $1.19M invested in NeuroMetrix, Inc. Common Stock in 2021 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 6 increasing their positions, 1 reducing their positions, and 2 closing their positions.
500% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 1
150% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 2
27% more funds holding
Funds holding: 11 → 14 (+3)
23% more capital invested
Capital invested by funds: $967K → $1.19M (+$225K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$168K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$49.1K |
| 3 |
VF
Virtu Financial
New York
|
+$40.1K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$23.1K |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$19.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Squarepoint
New York
|
-$73K |
| 2 |
TSS
Two Sigma Securities
New York
|
-$49K |
| 3 |
BlackRock
New York
|
-$872 |
NURO Hedge Fund Activity: Q2 2021 in Review
14 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in NeuroMetrix, Inc. Common Stock (NURO) for Q2 2021, worth a combined $1.19M — up 23% from $967K a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new NURO positions and 2 closed out — a net gain of 3 holders — while 6 added to existing stakes and 1 trimmed.
The largest buyer was Renaissance Technologies, adding an estimated $168K. The largest seller was Squarepoint, exiting entirely with an estimated $73K sold.
- 14 institutional investors held NeuroMetrix, Inc. Common Stock (NURO) as of Q2 2021, up from 11 in Q1 2021.
- Funds reported $1.19M of NeuroMetrix, Inc. Common Stock stock for Q2 2021, up 23% quarter-over-quarter.
- 5 funds opened new NeuroMetrix, Inc. Common Stock positions in Q2 2021 and 2 closed out, a net change of +3 holders.
- The largest NeuroMetrix, Inc. Common Stock buyer in Q2 2021 was Renaissance Technologies, an estimated $168K added.
- The largest NeuroMetrix, Inc. Common Stock seller in Q2 2021 was Squarepoint, an estimated $73K sold.
Based on aggregated 13F filings for Q2 2021.